Nasdaq: ASPE · Listed Oct 30, 2026
Aspen Neuroscience IPO
$12.25
▲ +2.08%today · -18.33% since the $15.00 IPO price
15-minute delayed · as of 7:32:35 PM EST on Nov 18, 2026
Aspen Neuroscience (ASPE) priced its IPO at $15.00 a share and has traded on Nasdaq since Oct 30, 2026.
Last session · Nov 18, 2026
- Market cap
- $349.23M
- from the ticker reference
- Volume
- 269.33K
- shares, regular session
- VWAP
- $12.35
- the last price is -0.78% from the volume-weighted average
- Day range
- 11.76–13.37
- low to high
The trading numbers are from the last session, Nov 18, 2026.
The debut race
ASPE against other big listings, as the percent change from each stock's own IPO price.
The first 30 trading days. Each point is the last regular-session trade of a day.
The first trading day.
The first trading day.
The IPO scoreboard
ASPE against 6 other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.
| IPO | Raised | First trade | Day 1 close | Day 1 close, as a bar | Day 5 | Day 30 |
|---|---|---|---|---|---|---|
| Aspen Neuroscience '26 | $140.63M | -2.00% | -7.13% | -21.87% | Not yet | |
| Figma '25 | $1.22B | +157.58% | +252.42% | +173.64% | +69.64% | |
| Circle '25 | $1.05B | +122.58% | +168.45% | +278.18% | +622.98% | |
| Reddit '24 | $748M | +38.24% | +47.97% | +69.90% | +40.32% | |
| Arm '23 | $5.23B | +10.00% | +23.76% | +3.63% | -3.06% | |
| Klarna '25 | $1.37B | +30.00% | +16.14% | +13.73% | -7.33% | |
| CoreWeave '25 | $1.5B | -2.50% | +0.02% | +34.32% | +28.42% |
Day 1 is the last regular-session trade of the first day. Day 5 and day 30 are the last trade of the fifth and thirtieth trading day, counting the listing day as day 1. A cell fills in when that day has traded.
The offering
The Aspen Neuroscience IPO offers 9.38M shares to raise $140.63M, before any underwriters' option.
- Expected price range
- $15 to $17
- IPO price
- $15.00
- Shares offered
- 9.38M
- Money raised
- $140.63M
- Listing date
- Oct 30, 2026
- Exchange
- Nasdaq
- Security
- Ordinary Shares
Money raised, against the largest IPOs
- Alibaba '14$21.77B
- Facebook '12$18.41B
- Rivian '21$11.93B
- Uber '19$8.1B
- Arm '23$5.23B
- Aspen Neuroscience$140.63M
Where ASPE ranks
Aspen Neuroscience's market cap against the largest US-listed companies.
Market cap, against the largest US-listed companies
- AAPL$5.12T
- MSFT$3.77T
- NVDA$3.65T
- GOOGL$3.47T
- AMZN$2.9T
- TSM$1.88T
- AVGO$1.69T
- META$1.58T
- TSLA$1.52T
- BRK.B$1.22T
- ASPE$349.23M
What comes after the IPO
Options, short interest, analyst ratings, and fund holdings are not available on day one. Each starts on its own date. A date marked est. follows usual market practice.
Oct 30, 2026
First trade
Prices, bars, and snapshots
Nov 4, 2026 · est.
Options list
Option chain and open interest
Nov 19, 2026 · est.
First short interest
Short interest and daily short volume
Nov 24, 2026 · est.
Quiet period ends
Analyst ratings and price targets
Feb 14, 2027
First 13F deadline
Which funds hold the stock
Date not set
First earnings
Income statement and ratios
Apr 27, 2027 · est.
Lock-up expires
Insider sales on Form 4
Filings and the company
What Aspen Neuroscience has disclosed to the SEC, and the basic facts about the listing.
8-K filings
Material events that Aspen Neuroscience discloses to the SEC on Form 8-K.
- Public offeringNov 2, 2026
On November 2, 2026, the Company completed the IPO of 9,375,000 shares of the Company's common stock, par value $0.0001 per share, at a price to the public of $15.00 per share. The gross proceeds to the Company from the IPO were approximately $140.6 million, before deducting underwriting discounts and commissions and offering expenses payable by the Company.
About Aspen Neuroscience
Aspen Neuroscience Inc is a clinical-stage, regenerative medicine biotechnology company focused on developing autologous induced-pluripotent stem cell (iPSC)-derived therapies to initially address neurodegenerative diseases with high unmet medical need. The company's flagship program, sasineprocel, is an investigational autologous iPSC-based therapy for Parkinson's disease designed to replace a patient's lost dopamine neurons with dopaminergic neuron precursor cells.
- Ticker
- ASPE
- Exchange
- Nasdaq
- Market
- stocks
- Type
- CS
- Currency
- USD
- Listed
- Oct 30, 2026
- Security
- Ordinary Shares
Frequently asked questions
What was the Aspen Neuroscience IPO price?
$15.00 a share.
When did Aspen Neuroscience go public?
Aspen Neuroscience listed on Nasdaq on Oct 30, 2026 under the ticker ASPE.
How much did the Aspen Neuroscience IPO raise?
$140.63M, before any underwriters' option.
How did Aspen Neuroscience open on its first day?
ASPE first traded at $14.70, -2.00% from the IPO price of $15.00.
How did ASPE close on its first day?
Its last regular-session trade was $13.93, -7.13% from the IPO price of $15.00.
What was the ASPE first-day trading range?
$11.60 to $14.90 in the regular session.
How many ASPE shares traded on the first day?
1.12M shares in the regular session.
How many shares did Aspen Neuroscience sell in its IPO?
9.38M shares.
What exchange is ASPE listed on?
Aspen Neuroscience lists on Nasdaq under the ticker ASPE.
Are the prices on this page real time?
No. Prices on this page are delayed 15 minutes. The Massive API and MCP server provide the most current data.
Build with Massive
Get the ASPE data behind this page
| What the page shows | Endpoint |
|---|---|
| Offering terms and dates | /vX/reference/ipos |
| Price | /v3/snapshot |
| Chart, VWAP, and the market comparison | /v2/aggs/ticker/ASPE/range/5/minute |
| Market cap | /v3/reference/tickers/ASPE |
| News | /v2/reference/news |
| Filings | /vX/disclosures |
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.